AbbVie: Credit Suisse reinstated coverage with a recommendation of outperform. PT set to $170.
Amgen: Credit Suisse reinstated coverage with a recommendation of underperform. PT set to $240.
Bakkavor: HSBC downgrades from buy to hold targeting GBp 90.10.
Bristol-Myers: Credit Suisse rei…
© MarketScreener.com 2022